Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1988 • 703 citations

RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)

2003 • 432 citations

Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study

2003 • 379 citations

The CAMPATH‐1 antigen (CDw52)

1990 • 334 citations

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

1999 • 306 citations

PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATION

1995 • 289 citations

Statistics with Confidence (2nd ed.)

2003 • 255 citations

FN18-CRM9 IMMUNOTOXIN PROMOTES TOLERANCE IN PRIMATE RENAL ALLOGRAFTS1

1997 • 212 citations

IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT‐MEDIATED LYSIS BY MONOCLONAL ANTIBODIES

1988 • 152 citations

Campath-1H in renal transplantation: The University of Wisconsin experience

2004 • 148 citations

The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

2004 • 122 citations

Prope tolerance: the future of organ transplantation—from the laboratory to the clinic

2004 • 49 citations

Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.

1995 • 39 citations

Clinical Tolerance: the end of the beginning

2004 • 8 citations